LEONARD A LEVIN, MD PHD
Medical Practice at University Ave, Madison, WI
License number
Wisconsin 34469
Category
Medical Practice
Type
Ophthalmology
Address
Address
2880 University Ave, Madison, WI 53717
Phone
(608) 263-7171
(608) 265-8060 (Fax)
(608) 265-8060 (Fax)
Organization information
See more information about LEONARD A LEVIN at bizstanding.comLeonard A Levin MD
600 Highland Ave #G3275, Madison, WI 53792
Categories:
Physicians & Surgeons
Phone:
(608) 262-3147 (Phone)
Professional information
Leonard A Levin, Madison WI
Specialties:
Ophthalmologist
Address:
2880 University Ave, Madison, WI 53705
Limited To Official University Duties On, Madison, WI 53792
Limited To Official University Duties On, Madison, WI 53792
Education:
Harvard Medical School - Doctor of Medicine
Harvard University - Doctor of Philosophy
Massachusetts Eye & Ear Infirmary - Fellowship - Neuro-Ophthalmology
Massachusetts Eye & Ear Infirmary - Residency - Ophthalmology
Harvard University - Doctor of Philosophy
Massachusetts Eye & Ear Infirmary - Fellowship - Neuro-Ophthalmology
Massachusetts Eye & Ear Infirmary - Residency - Ophthalmology
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Dr. Leonard A Levin, Madison WI - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
2870 University Ave STE 206, Madison 53705
(608) 263-6070 (Phone)
University Of Wisconsin Hospital OPH
2880 University Ave, Madison 53705
(608) 263-6070 (Phone)
(608) 263-6070 (Phone)
University Of Wisconsin Hospital OPH
2880 University Ave, Madison 53705
(608) 263-6070 (Phone)
Certifications:
Ophthalmology, 1994
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
2870 University Ave STE 206, Madison 53705
University Of Wisconsin Hospital OPH
2880 University Ave, Madison 53705
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
University Of Wisconsin Hospital OPH
2880 University Ave, Madison 53705
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
Harvard Medical School
Graduated: 1988
Mt Auburn Hospital
Graduated: 1989
Mass Ee Infirm
Graduated: 1992
Graduated: 1993
Harvard Medical School
Graduated: 1988
Mt Auburn Hospital
Graduated: 1989
Mass Ee Infirm
Graduated: 1992
Graduated: 1993
Methods And Compositions For Reducing Neuronal Cell Death
US Patent:
2011019, Aug 11, 2011
Filed:
Mar 18, 2011
Appl. No.:
13/051371
Inventors:
RONALD T. RAINES - Madison WI, US
Leonard A. Levin - Madison WI, US
Leonard A. Levin - Madison WI, US
Assignee:
WISCONSIN ALUMNI RESEARCH FOUNDATION - Madison WI
International Classification:
A61K 31/69, A61P 25/00
US Classification:
514 64
Abstract:
Methods and compositions involving a class of boron-protected phenylphosphine agents having increased cell permeability and having improved chemical stability for treating or for preventing neuronal cell death-related diseases or conditions in a human or a non-human animal.
In Vitro-Differentiated Retinal Ganglion Cells And Method For Producing Same
US Patent:
7303915, Dec 4, 2007
Filed:
Feb 24, 2006
Appl. No.:
11/361342
Inventors:
Leonard A. Levin - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C12N 5/00, C12N 5/06
US Classification:
435375, 435325, 435353, 435377
Abstract:
In vitro-differentiated retinal ganglion cells can be produced by exposing a mammalian retinal ganglion cell line to a protein kinase inhibitor. The differentiated retinal ganglion cells can be used to identify agents that protect retinal ganglion cells in vivo or in vitro from cell injury (including cell death) and agents that affect retinal ganglion cell ion channel activity.
Methods Of And Compositions For Reducing Neuronal Cell Death
US Patent:
7932239, Apr 26, 2011
Filed:
Apr 27, 2006
Appl. No.:
11/412353
Inventors:
Ronald T. Raines - Madison WI, US
Leonard A. Levin - Madison WI, US
Leonard A. Levin - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A01N 55/08, A01N 57/00, A61K 31/69, A61K 31/66, C07F 5/02, C07F 9/02
US Classification:
514 64, 514 75, 514120, 568 2, 568 6, 568 8, 568 13, 568 17
Abstract:
Methods and compositions involving a class of boron-protected phenylphosphine agents having increased cell permeability and having improved chemical stability for treating or for preventing neuronal cell death-related diseases or conditions in a human or a non-human animal.
Methods Of And Compositions For Reducing Cell Death
US Patent:
8415327, Apr 9, 2013
Filed:
Feb 22, 2010
Appl. No.:
12/710215
Inventors:
Leonard A. Levin - Madison WI, US
Yun Luo - Madison WI, US
Yun Luo - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 31/69, C07C 69/612, C07F 5/02, A61P 43/00, C12N 5/07, C12N 5/071
US Classification:
514 64, 560105, 564 8, 435325, 435366, 435404
Abstract:
Methods and compositions involving a class of boron-protected phenylphosphine agents having increased cell permeability and having improved chemical stability for treating or for preventing cell death-related diseases or conditions in a human or a non-human animal.
Method Of Reducing Retinal Ganglion Cell Degeneration
US Patent:
6291506, Sep 18, 2001
Filed:
Aug 3, 1999
Appl. No.:
9/366525
Inventors:
Leonard A Levin - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 3140
US Classification:
514411
Abstract:
Disclosed is a method of reducing intraocular pressure or retinal ganglion cell death caused by specific reactive oxygen species by delivering carvedilol or a derivative or metabolite thereof having beta-adrenergic antagonist activity or specific reactive oxygen species scavenging activity to the retinal ganglion cells of a subject having or at risk of developing glaucomatous or other optic neuropathy.
In Vitro-Differentiated Retinal Ganglion Cells And Method For Producing Same
US Patent:
2008008, Apr 3, 2008
Filed:
Dec 3, 2007
Appl. No.:
11/949547
Inventors:
Leonard Levin - Madison WI, US
International Classification:
C12Q 1/02, C12N 5/06
US Classification:
435029000, 435377000
Abstract:
In vitro-differentiated retinal ganglion cells can be produced by exposing a mammalian retinal ganglion cell line to a protein kinase inhibitor. The differentiated retinal ganglion cells can be used to identify agents that protect retinal ganglion cells in vivo or in vitro from cell injury (including cell death) and agents that affect retinal ganglion cell ion channel activity.